These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 12173133)

  • 41. [Antibody pattern in patients with different forms of leishmaniasis (author's transl)].
    Mannweiler E; Lederer I; zum Felde I
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(3):397-402. PubMed ID: 352039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety of a pre-formulated amphotericin B lipid emulsion for the treatment of Indian Kala-azar.
    Sundar S; Chakravarty J; Agarwal D; Shah A; Agrawal N; Rai M
    Trop Med Int Health; 2008 Sep; 13(9):1208-12. PubMed ID: 18664241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kala-azar epidemic in Varanasi district, India.
    Kumar R; Kumar P; Chowdhary RK; Pai K; Mishra CP; Kumar K; Pandey HP; Singh VP; Sundar S
    Bull World Health Organ; 1999; 77(5):371-4. PubMed ID: 10361752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Visceral leishmaniasis (kala-azar) in Fars Province, Iran: study of 130 cases.
    Hashemi-Nasab A; Zadeh-Shirazi H
    J Trop Med Hyg; 1980 Jun; 83(3):119-22. PubMed ID: 7401218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resurgence of visceral leishmaniasis in Bangladesh.
    Rahman KM; Islam N
    Bull World Health Organ; 1983; 61(1):113-6. PubMed ID: 6601534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR.
    Manna M; Majumder HK; Sundar S; Bhaduri AN
    Med Sci Monit; 2005 Jul; 11(7):BR220-7. PubMed ID: 15990683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative evaluation of parasitology and serological tests in the diagnosis of visceral leishmaniasis in India: a phase III diagnostic accuracy study.
    Sundar S; Singh RK; Bimal SK; Gidwani K; Mishra A; Maurya R; Singh SK; Manandhar KD; Boelaert M; Rai M
    Trop Med Int Health; 2007 Feb; 12(2):284-9. PubMed ID: 17300637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh.
    Bern C; Amann J; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Wagatsuma Y; Breiman RF; Secor WE; Maguire JH
    Am J Trop Med Hyg; 2006 Oct; 75(4):744-8. PubMed ID: 17038705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of visceral leishmaniasis: Indian perspective.
    Agrawal S; Rai M; Sundar S
    J Postgrad Med; 2005; 51 Suppl 1():S53-7. PubMed ID: 16519257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of age and sex on incidence of kala-azar.
    Sharma MC; Gupta AK; Saran R; Sinha SP
    J Commun Dis; 1990 Dec; 22(4):277-8. PubMed ID: 2098434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for Indian kala-azar.
    Ranjan A; Sur D; Singh VP; Siddique NA; Manna B; Lal CS; Sinha PK; Kishore K; Bhattacharya SK
    Am J Trop Med Hyg; 2005 Jul; 73(1):74-8. PubMed ID: 16014837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunoblotting identifies an antigen recognized by anti gp63 in the immune complexes of Indian kala-azar patient sera.
    Sanyal T; Ghosh DK; Sarkar D
    Mol Cell Biochem; 1994 Jan; 130(1):11-7. PubMed ID: 8190117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Diagnosis of kala-azar. II. Study of Montenegro's test and detection of Leishmania in skin material from patients with kala-azar, before and after antimony treatment].
    Mayrink W; Magalhàes PA; Batista SM; da Costa CA
    Rev Inst Med Trop Sao Paulo; 1971; 13(4):268-71. PubMed ID: 5132387
    [No Abstract]   [Full Text] [Related]  

  • 55. Identification of immune complex antigens in sera of Indian kala-azar patients.
    Sanyal T; Ghosh DK; Sarkar D
    Indian J Exp Biol; 1991 May; 29(5):411-5. PubMed ID: 1916938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review.
    Hernández-Pérez J; Yebra-Bango M; Jiménez-Martínez E; Sanz-Moreno C; Cuervas-Mons V; Alonso Pulpón L; Ramos-Martínez A; Fernández-Fernández J
    Clin Infect Dis; 1999 Oct; 29(4):918-21. PubMed ID: 10589910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of sodium antimony gluconate and ketoconazole in the treatment of kala-azar--a comparative study.
    Wali JP; Aggarwal P; Nandy A; Singh S; Addy M; Guha SK; Dwivedi SN; Karmarkar MG; Maji AK
    J Commun Dis; 1997 Jun; 29(2):73-83. PubMed ID: 9282505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis.
    Sundar S; Jha TK; Sindermann H; Junge K; Bachmann P; Berman J
    Pediatr Infect Dis J; 2003 May; 22(5):434-8. PubMed ID: 12792385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of rK39 strip test for the diagnosis of visceral leishmaniasis in infants.
    Alborzi A; Rasouli M; Nademi Z; Kadivar MR; Pourabbas B
    East Mediterr Health J; 2006; 12(3-4):294-9. PubMed ID: 17037697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune complexes in Indian kala-azar.
    Sehgal S; Aikat BK; Pathania AG
    Bull World Health Organ; 1982; 60(6):945-50. PubMed ID: 6761008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.